Showing 20 of 80 recruiting trials for “thrombotic-thrombocytopenic-purpura”
Safety Study of CC312 in Autoimmune Disease Patients
RecruitingNCT06727669 ↗
Longitudinal Cohort of Thrombosis and Hemostasis Diseases
👨⚕️ Xiao-Hui Zhang, MD, Peking University Institute of Hematology, Peking University People's Hospital📍 5 sites📅 Started Nov 2024View details ↗
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
RecruitingNCT06919341 ↗
RESTI Registry: Spanish Registry of Primary Immune Thrombocytopenia and Other Immune Thrombocytopenia
RecruitingNCT06817395 ↗
Cognitive Dysfunction in Chronic and Persistent Immune Thrombocytopenia
BCMA-CD19 CCAR T Cell Treatment of Refractory Immune Thrombocytopenia Associated with Autoimmune Diseases
An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune Thrombocytopenia
Safety and Efficacy of PRG-1801 in Recurrent/Refractory Primary Immune Thrombocytopenia (ITP)
👨⚕️ Heng Mei, Ph.D&M.D, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology📍 2 sites📅 Started Aug 2024View details ↗
Anti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP)
👨⚕️ Lei Zhang, MD, Chinese Academy of Medical Science and Blood Disease Hospital📍 1 site📅 Started Aug 2024View details ↗
The Efficacy and Safety of HCQ Plus TPO-RA in ANA Positive ITP
TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination
👨⚕️ Tienan Zhu, M.D., Peking Union Medical College Hospital📍 1 site📅 Started Jun 2024View details ↗
A Study of Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITP
RecruitingNCT06441578 ↗
A Survey of Recombinant ADAMTS13 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
The Efficacy and Safety of HCQ Plus Pred in ANA Positive ITP
The Efficacy and Safety of HCQ Plus DEX in ANA Positive ITP
Avatrombopag in the Treatment of Pediatric Immune Thrombocytopenia
👨⚕️ Lei Zhang, MD, Institute of Hematology & Blood Diseases Hospital, China📍 1 site📅 Started Mar 2024View details ↗
Efficacy and Safety of CAR-T Cells Therapy for Chronic or Refractory Primary Immune Thrombocytopenia (ITP)
👨⚕️ Sanbin Wang, Doctor, 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China📍 1 site📅 Started Feb 2024View details ↗
Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP)
👨⚕️ Lei Zhang, MD, Chinese Academy of Medical Science and Blood Disease Hospital📍 1 site📅 Started Dec 2023View details ↗
A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP)
👨⚕️ Lei Zhang, MD, Chinese Academy of Medical Science and Blood Disease Hospital📍 1 site📅 Started Dec 2023View details ↗
Biologic Characterization of Patients With ITP
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →